Non-hodgkin Lymphoma Genomics
- Cancer PHGKB -
What's New
Last Posted: Feb 20, 2019
- Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes.
Shin Seung-Ho et al. Leukemia & lymphoma 2019 Feb 1-10 - Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.
Galanina Natalie et al. Cancers 2018 Dec 11(1) - Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Dunleavy Kieron et al. The Lancet. Haematology 2018 Dec 5(12) e609-e617 - Challenges and implications of genomics for T-cell lymphomas.
Jacobsen Eric D et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 63-68 - Genomics of aggressive B-cell lymphoma.
Rosenthal Allison et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 69-74 - Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma.
Wu Fang-Tian et al. Annals of hematology 2018 Oct - Tailoring front-line therapy in diffuse large B-cell lymphoma: who should we treat differently?
Davies Andrew et al. Hematology. American Society of Hematology. Education Program 2017 2017(1) 284-294 - The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.
de Mel Sanjay et al. International journal of molecular sciences 2018 Jun 19(7) - Cytochrome P450 Genetic Variations Can Predict mRNA Expression, Cyclophosphamide 4-Hydroxylation, and Treatment Outcomes in Chinese Patients With Non-Hodgkin's Lymphoma.
Shu Wenying et al. Journal of clinical pharmacology 2017 Jul 57(7) 886-898 - Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.
Dubois Sydney et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jun 22(12) 2919-28 - Precision Medicine for Diffuse Large B-cell Lymphoma.
Lim Megan S et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jun 22(12) 2829-31 - The Promise and Challenges of CAR-T Gene Therapy.
Kuehn Bridget M et al. JAMA 2017 Nov - Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma.
Chen Qiushi et al. Leukemia & lymphoma 2017 Oct 1-10 - Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.
Samadder N Jewel et al. JAMA oncology 2017 Aug - BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.
Huet Sarah et al. American journal of hematology 2017 Jun 92(6) 515-519
No hay comentarios:
Publicar un comentario